Goldstein, F., Rothman, K.J.. Epidemiology of pelvic inflammatory disease. Epidemiology 1994; 5: 234–242.CrossRefGoogle Scholar

Landers, D.V., Sweet, R.L.. Current trends in the diagnosis and treatment of tubo-ovarian abscess. Am J Obstet Gynecol 1985; 151: 1098–1110.Google Scholar

Scully, R.E., Young, R.H., Clement, P.B.. Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament. In: Atlas of Tumor Pathology, third series. Fascicle 23. Washington, DC: Armed Forces Institute of Pathology; 1998: 409–450.Google Scholar

Wetchler, S.J., Dunn, L.J.. Ovarian abscess: report of a case and review of the literature. Obstet Gynecol Surv 1985; 40: 476–485.Google Scholar

Muller-Holzner, E., Ruth, N.R., Abfalter, E., et al. IUD-associated pelvic actinomycosis: a report of five cases. Int J Gynecol Pathol 1995; 14: 70–74.Google Scholar

Subietas, A., Deppisch, L.M., Astarloa, J.. Cytomegalovirus oophoritis: ovarian cortical necrosis. Hum Pathol 1977; 8:285–292.Google Scholar

Iwasaki, T., Sakuma, T., Satodate, R., et al. Cytomegalovirus oophoritis with cortical necrosis during remission of acute lymphocytic leukaemia. Acta Pathol Jpn 1988; 38: 1069–1076.Google Scholar

Nogales-Ortiz, F., Tarancon, I., Nogales, F.F. Jr. The pathology of female genital tract tuberculosis: a 31-year study of 1,436 cases. Obstet Gynecol 1979; 53: 422–428.Google Scholar

Navamar Jahromi, B., Parsanezhad, M.E., Ghane-Shirazi, R.. Female genital tuberculosis and infertility. Int J Gynecol Obstet 2001; 75: 269–272.Google Scholar

Tiboldi, T.. Involvement of human and primate ovaries in schistosomiasis: a review of the literature. Ann Soc Belg Med Trop 1978; 58: 9–20.Google Scholar

McMahon, J.N., Connolly, C.E., Long, S.V., et al. Enterobius granulomas of the uterus, ovary and pelvic peritoneum: two case reports. Br J Obstet Gynaecol 1984; 91: 289–290.CrossRefGoogle ScholarPubMed

Chalvardjian, A., Picard, L., Shaw, R., et al. Malacoplakia of the female genital tract. Am J Obstet Gynecol 1980; 138: 391–394.CrossRefGoogle ScholarPubMed

McCluggage, W.G., Allen, D.C.. Ovarian granulomas: a report of 32 cases. J Clin Pathol 1997; 50: 324–327.CrossRefGoogle ScholarPubMed

Kim, K.R., Scully, R.E.. Peritoneal keratin granulomas with carcinoma of endometrium and ovary and atypical polypoid adenomyoma: a clinicopathological analysis of 22 cases. Am J Surg Pathol 1990; 14: 925–932.Google Scholar

Frost, S.S., Elstein, M.P., Latour, F., et al. Crohn’s disease of the mouth and ovary. Digest Dis Sci 1981; 26:568–571.Google Scholar

Kernohan, N.M., Best, P.V., Jandial, V., Kitchener, H.C.. Palisading granuloma of the ovary. Histopathology 1991; 19:279–280.Google Scholar

Strickler, R.C., Kelly, R.W., Askin, F.B.. Postmenopausal ovarian follicle cyst: an unusual cause of estrogen excess. Int J Gynecol Pathol 1984; 3: 318–322.Google Scholar

Widdowson, D.J., Pilling, D.W., Cook, R.C.. Neonatal ovarian cysts: therapeutic dilemma. Arch Dis Child 1988; 63: 737–742.Google Scholar

Danon, M., Robboy, S.J., Kim, S., et al. Cushing’s syndrome, sexual precocity and polyostotic fibrous dysplasia (Albright’s syndrome) in infancy. J Pediatr 1975; 87: 917–921.CrossRefGoogle ScholarPubMed

Symmonds, R.E., Pettit, P.D.. Ovarian remnant syndrome. Obstet Gynecol 1979; 54; 174–177.Google ScholarPubMed

Abu-Rafeh, B., Vilos, G.A., Misra, M.. Frequency and laparoscopic management of ovarian remnant syndrome. J Am Assoc Gynecol Laparosc 2003; 10: 33–37.Google Scholar

Franks, S.. Polycystic ovary syndrome. N Engl J Med 1995; 333: 853–861.Google Scholar

Stein, I.F., Leventhal, M.L.. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935; 29: 181–191.CrossRefGoogle Scholar

Rosenfield, R.L., Barnes, R.B., Cara, J.F., Lucky, A.W.. Dysregulation of cytochrome P450 c 17 alpha as the cause of the polycystic ovarian syndrome. Fertil Steril 1990; 53: 785–791.CrossRefGoogle Scholar

Dunaif, A., Thomas, A.. Current concepts in the polycystic ovary syndrome. Annu Rev Med 2001; 52: 401–419.CrossRefGoogle ScholarPubMed

Hardiman, P., Pillary, O.S., Atiomo, W.. Polycystic ovary syndrome and endometrial carcinoma. Lancet 2003; 361: 1810–1812.CrossRefGoogle ScholarPubMed

Sasano, H., Fukunaga, M., Rojas, M., Silverberg, S.G.. Hyperthecosis of the ovary: clinicopathologic study of 19 cases with immunohistochemical analysis of steroidogenic enzymes. Int J Gynecol Pathol 1989; 8:311–320.CrossRefGoogle Scholar

Imperato-McGinley, J., Peterson, R.E., Sturla, E., et al. Primary amenorrhea associated with hirsutism, acanthosis nigricans, dermoid cysts of the ovaries and a new type of insulin resistance. Am J Med 1978; 65: 389–395.Google Scholar

Kalstone, C.E., Jaffe, R.B., Abell, M.R.. Massive edema of the ovary simulating fibroma. Obstet Gynecol 1969; 34: 564–571.Google Scholar

Young, R.H., Scully, R.E.. Fibromatosis and massive edema of the ovary, possibly related entities: a report of 14 cases of fibromatosis and 11 cases of massive edema. Int J Gynecol Pathol 1984; 3: 153–178.CrossRefGoogle Scholar

Sternberg, W.H.. The Ovary, Grady, H.G., Smith, D.E., editors, International Academy of Pathology Monograph, no 3. Baltimore, MD: Williams & Wilkins; 1962: 234.Google Scholar

Malinak, L.R., Miller, G.V.. Bilateral multicentric ovarian luteomas of pregnancy associated with masculinization of a female infant. Am J Obstet Gynecol 1965; 91: 251–259.Google Scholar

Wajda, K.J., Lucas, J.G., Marsh, W.L.. Hyperreactio luteinalis: benign disorder masquerading as an ovarian neoplasm. Arch Pathol Lab Med 1989; 113: 921–925.Google Scholar

Clement, P.B.. Tumor-like lesions of the ovary associated with pregnancy. Int J Gynecol Pathol 1993; 12: 108–115.Google Scholar

Waterstone, J.J., Summers, B.A., Hoskins, M.C., et al. Ovarian hyperstimulation syndrome and deep cerebral venous thrombosis. Br J Obstet Gynaecol 1992; 99: 439–440.CrossRefGoogle ScholarPubMed

Vasseur, C., Rodien, P., Beau, I., et al. A chorionic gonadotropin-sensitive mutation in the follicle-stimulating hormone receptor as a cause of familial gestational spontaneous ovarian hyperstimulation syndrome. N Engl J Med 2003; 349: 753–759.Google Scholar

Smits, G., Olatunbosun, O., Delbaere, A., et al. Ovarian hyperstimulation syndrome due to mutation in the follicle-stimulating hormone receptor. N Engl J Med 2003; 349: 760–766.Google Scholar

Clement, P.B., Scully, R.E.. Large solitary luteinized follicle cyst of pregnancy and puerperium: a clinicopathological analysis of eight cases. Am J Surg Pathol 1980; 4: 431–438.CrossRefGoogle ScholarPubMed

Clement, P.B., Young, R.H., Scully, R.E.. Ovarian granulosa cell proliferations of pregnancy: a report of nine cases. Hum Pathol 1988; 19: 657–662.Google Scholar

Verhoeven, G.F.M., Wilson, J.D.. The syndromes of primary hormone resistance. Metabolism 1979; 28: 253–289.CrossRefGoogle ScholarPubMed

Coulam, C.B., Ryan, R.J.. Prevalence of circulating antibodies directed toward ovaries among women with premature ovarian failure. Am J Reprod Immunol Microbiol 1985; 9: 23–24.CrossRefGoogle ScholarPubMed

Biscotti, C.V., Hart, W.R., Lucas, J.G.. Cystic ovarian enlargement resulting from autoimmune oophoritis. Obstet Gynecol 1989; 74: 492–495.Google ScholarPubMed

Bannatyne, P., Russell, P., Shearman, R.P.. Autoimmune oophoritis: a clinicopathologic assessment of 12 cases. Int J Gynecol Pathol 1990; 9: 191–207.Google Scholar

Arif, S., Vallian, S., Farzaneh, F., et al. Identification of 3 beta hydroxysteroid dehydrogenase as a novel target of steroid cell autoantibodies: association of autoantibodies with endocrine autoimmune disease. J Clin Endocrinol Metab 1996; 81: 4439–4445.Google ScholarPubMed

Rosai, J.. Uterus-like mass replacing ovary [Letter]. Arch Pathol Lab Med 1982; 106: 364–365.Google Scholar

Pai, S.A., Desai, S.B., Borges, A.M.. Uterus-like masses of the ovary associated with breast cancer and raised serum CA 125. Am J Surg Pathol 1998; 22: 333–337.Google Scholar

Jeyaratnam, R., Bakalinova, D.. Cystic dysplasia of the rete testis: a case of spontaneous regression and review of published reports. Urology 2010; 7: 687–690.CrossRefGoogle Scholar

Nistal, M., González-Peramato, P., Sousa, G., et al. Cystic dysplasia of the epididymis: a disorder of mesonephric differentiation associated with renal maldevelopment. Virchows Arch 2010; 456: 695–702.CrossRefGoogle ScholarPubMed

Hung, N.A., Silver, M.M., Chitayat, D., et al. Gonadoblastoid testicular dysplasia in Walker-Warburg syndrome. Pediatr Dev Pathol 1998; 1: 393–404.Google Scholar

Nistal, M., Rodríguez, J.I., García-Fernández, E., et al. Fetal gonadoblastoid testicular dysplasia: a focal failure of testicular development. Pediatr Dev Pathol 2007; 10: 274–281.Google Scholar

Vallangeon, B.D., Eble, J.N., Ulbright, T.M.. Macroscopic sertoli cell nodule: a study of 6 cases that presented as testicular masses. Am J Surg Pathol 2010; 34: 1874–1880.Google Scholar

Nistal, M., Paniagua, R., Gonzalez-Peramato, P.. Nonneoplastic diseases of the testis. In Bostwick, D.G., Cheng, L., editors, Urologic Surgical Pathology, 3rd edn. Philadelphia, PA: Saunders; 2014, p. 560–735.Google Scholar

Rutgers, J.L., Scully, R.E.. The androgen insensitivity syndrome (testicular feminization): a clinicopathologic study of 43 cases. Int J Gynecol Pathol 1991; 10: 126–144.CrossRefGoogle ScholarPubMed

Barton, J.H., Davis, C.J. Jr, Sesterhenn, I.A., et al. Smooth muscle hyperplasia of the testicular adnexa clinically mimicking neoplasia: clinicopathologic study of sixteen cases. Am J Surg Pathol 1999; 23: 903–909.Google Scholar

Cajaiba, M.M., Garcia-Fernandez, E., Reyes-Mugica, M., et al. The spectrum of persistence of testicular blastema and ectopic testicular parenchyma: a possible result of focal delay in gonadal development. Virchows Arch 2007; 451: 89–94.CrossRefGoogle ScholarPubMed

Nistal, M., Paniagua, R., González-Peramato, P., et al. Perspectives in pediatric pathology, Chapter 10: ectopic and heterotopic tissues in the testis. Pediatr Dev Pathol 2015; 18: 446–457.Google Scholar

Nistal, M., Paniagua, R., Leon, L., et al. Ectopic seminiferous tubules in the tunica albuginea of normal and dysgenetic testes. Appl Pathol 1985; 3: 123–128.Google Scholar

Regadera, J., Codesal, J., Paniagua, R., et al. Immunohistochemical and quantitative study of interstitial and intratubular Leydig cells in normal men, cryptorchidism, and Klinefelter’s syndrome. J Pathol 1991; 164: 299–306.CrossRefGoogle ScholarPubMed

Nistal, M., Paniagua, R.. Histogenesis of human extraparenchymal Leydig cells. Acta Anat (Basel) 1979; 105: 188–197.Google Scholar

Okur, H., Kucukaydin, M., Kazez, A., et al. Ectopic adrenal tissue in the inguinal region in children. Pediatr Pathol Lab Med 1995; 15: 763–767.Google Scholar

Paner, G.P., Kristiansen, G., McKenney, J.K., et al. Rete testis-associated nodular steroid cell nests: description of putative pluripotential testicular hilus steroid cells. Am J Surg Pathol 2011;35: 505–511.Google Scholar

Mikuz, G.. Testicular torsion: simple grading for histological evaluation of tissue damage. Appl Pathol 1985; 3: 134–139.Google ScholarPubMed

Nistal, M., Martinez, C., Paniagua, R.. Primary testicular lesions in the twisted testis. Fertil Steril 1992; 57: 381–386.CrossRefGoogle ScholarPubMed

Nistal, M., Paniagua, R., Gonzalez-Peramato, P., et al. Perspectives in pediatric pathology, Chapter 19: testicular torsion, testicular appendix torsion and other forms of testicular infarction. Pediatr Dev Pathol 2014; 19: 345–359.Google Scholar

Hernández-Rodríguez, J., Tan, C.D., Koening, C.L., et al. Testicular vasculitis: findings differentiating isolated disease from systemic disease in 72 patients. Medicine (Baltimore) 2012; 91: 75–85.Google Scholar

Nistal, M., González-Peramato, P.. Vascular testis pathology. In: Jezek, D., editor, Atlas on the Human Testis. London: Springer-Verlag; 2013, p. 243–251.Google Scholar

Dufour, J.F., Le Gallou, T., Cordier, J.F., et al; French Center-East Internists Group; French Vasculitis Study Group. Urogenital manifestations in Wegener granulomatosis: a study of 11 cases and review of the literature. Medicine (Baltimore) 2012; 91: 67–74.Google Scholar

Arnillas, E., de la Fuente, J., Núñez, M., et al. Giant cell arteritis with epididymal involvement. Med Clin (Barc) 2009; 132: 485.Google Scholar

Trojian, T.H., Lishnak, T.S., Heiman, D.. Epididymitis and orchitis: an overview. Am Fam Physician 2009; 79: 583–587.Google Scholar

Algaba, F., Santaularia, J.M., Garat, J.M., et al. Testicular pseudolymphoma. Eur Urol 1986; 12: 362–363.CrossRefGoogle ScholarPubMed

Nistal, M., Mate, A., Paniagua, R.. Granulomatous epididymal lesion of possible ischemic origin. Am J Surg Pathol 1997; 21: 951–956.Google Scholar

Hajri, M., Amna, M.B., Derouich, A., et al. Xanthogranulomatous orchitis: report of 7 cases. Ann Urol (Paris) 2001; 35: 237–239.Google Scholar

Wang, C.C., Al-Hussain, T.O., Serrano-Olmo, J., et al. Rosai–Dorfman disease of the genito-urinary tract: analysis of six cases from the testis and kidney. Histopathology 2014; 65: 908–916.Google Scholar

Sheu, S.Y., Wenzel, R.R., Kersting, C., et al. Erdheim–Chester disease: case report with multisystemic manifestations including testes, thyroid, and lymph nodes, and a review of literature. J Clin Pathol 2004; 57: 1225–1228.Google Scholar

Kapoor, R., Ansari, M.S., Mandhani, A., et al. Clinical presentation and diagnostic approach in cases of genitourinary tuberculosis. Indian J Urol 2008; 24: 401–405.Google Scholar

Chu, C.Y., Chen, W.Y., Yeh, S.D., et al. Syphilitic orchitis mimicking a testicular tumor in a clinically occult HIV-infected young man: a case report with emphasis on a challenging pathological diagnosis. Diagn Pathol 2016; 11: 4.CrossRefGoogle Scholar

Bosilkovski, M., Kamiloski, V., Miskova, S., et al. Testicular infection in brucellosis: report of 34 cases. J Microbiol Immunol Infect 2018; 51: 82–87.CrossRefGoogle ScholarPubMed

Roy, S., Hooda, S., Parwani, A.V.. Idiopathic granulomatous orchitis. Pathol Res Pract 2011; 207: 275–278.Google Scholar

Haddad, F.S., Manne, R.K., Nathan, M.H.. The pathological, ultrasonographic and computerized tomographic characteristics of chronic hematocele. J Urol 1988; 139: 594–595.Google Scholar

Alanbuki, A.H., Bandi, A., Blackford, N.. Meconium periorchitis: a case report and literature review. Can Urol Assoc J 2013; 7: E495–E498.Google Scholar

Chekol, S.S., Sun, C.C.. Malignant mesothelioma of the tunica vaginalis testis: diagnostic studies and differential diagnosis. Arch Pathol Lab Med 2012; 136: 113–117.CrossRefGoogle ScholarPubMed

Lee, S., Illei, P.B., Han, J.S., Epstein, J.I.. Florid mesothelial hyperplasia of the tunica vaginalis mimicking malignant mesothelioma: a clinicopathologic study of 12 cases. Am J Surg Pathol 2014; 38: 54–59.Google Scholar

Weingarten, B.J., Kellman, G.M., Middleton, W.D., et al. Tubular ectasia within the mediastinum testis. J Ultrasound Med 1992; 11: 349–353.Google Scholar

Nistal, M., Mate, A., Paniagua, R.. Cystic transformation of the rete testis. Am J Surg Pathol 1996; 20: 1231–1239.Google Scholar

Nistal, M., Castillo, M.C., Regadera, J., et al. Adenomatous hyperplasia of the rete testis: a review and report of new cases. Histol Histopathol 2003; 18: 741–752.Google Scholar

Ulbright, T.M., Gersell, D.J.. Rete testis hyperplasia with hyaline globule formation. A lesion simulating yolk sac tumor. Am J Surg Pathol 1991; 15: 66–74.Google Scholar

Nistal, M., Paniagua, R.. Nodular proliferation of calcifying connective tissue in the rete testis: a study of three cases. Hum Pathol 1989; 20: 58–61.Google Scholar

Oliva, E., Young, R.H.. Paratesticular tumor-like lesions. Semin Diagn Pathol 2000; 17: 340–358.Google ScholarPubMed

López-Beltran, A., Menendez, C.L., Montironi, R., Cheng, L.. Testicular and paratesticular structures. In: Rare Tumors and Tumor-like Conditions. Dordrecht: Springer; 2015, p. 311–367.Google Scholar

Nistal, M., Mate, A., Paniagua, R.. Granulomatous epididymal lesion of possible ischemic origin. Am J Surg Pathol 1997; 21: 951–956.CrossRefGoogle ScholarPubMed

Dunner, P.S., Lipsit, E.R., Nochomovitz, L.E.. Epididymal sperm granuloma simulating a testicular neoplasm. J Clin Ultrasound 1982; 10: 353–355.Google Scholar

Unal, D., Kilic, M., Oner, S., et al. Cholesterol granuloma of the paratesticular tissue: a case report. Can Urol Assoc J 2015; 9: E390–E392.Google Scholar

Young, R.H., Scully, R.E.. Testicular and paratesticular tumors and tumor-like lesions of ovarian common epithelial and müllerian types. A report of four cases and review of the literature. Am J Clin Pathol 1986; 86: 146–152.Google Scholar

Nistal, M., González-Peramato, P., Serrano, A., et al. Paratesticular cysts with benign epithelial proliferations of wolffian origin. Am J Clin Pathol 2005; 124: 245–251.Google Scholar

Bösmüller, H., von Weyhern, C.H., Adam, P., et al. Paratesticular fibrous pseudotumor–an IgG4-related disorder? Virchows Arch 2011; 458: 109–113.Google Scholar

Oertel, Y.C., Johnson, F.B.. Sclerosing lipogranuloma of male genitalia: review of 23 cases. Arch Pathol Lab Med 1977; 101: 321–326.Google Scholar

Lee, P.A., Houk, C.P., Ahmed, S.F., et al; International Consensus Conference on Intersex organized by the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. Consensus statement on management of intersex disorders. International Consensus Conference on Intersex. Pediatrics 2006; 118: e488–e500.Google Scholar

Lee, P.A., Nordenström, A., Houk, C.P., et al; Global DSD Update Consortium. Global disorders of sex development update since 2006: perceptions, approach and care. Horm Res Paediatr 2016; 85: 158–180.Google Scholar

Mieszczak, J., Houk, C.P., Lee, P.A.. Assignment of the sex of rearing in the neonate with a disorder of sex development. Curr Opin Pediatr 2009; 21: 541–547.Google Scholar

Ostrer, H.. Disorders of sex development (DSDs): an update. J Clin Endocrinol Metab 2014; 99: 1503–1509.Google Scholar

Damiani, D., Guerra-Júnior, G.. New definitions and classifications of the intersexual states: in which the Chicago Consensus has contributed to the state of the art? Arq Bras Endocrinol Metabol 2007; 51: 1013–1017.Google Scholar

Nistal, M., Gonzalez-Peramato, P.. Disorders of sex development. In: Jezek, D., editor, Atlas on the Human Testis: Normal Morphology and Pathology. London: Springer Verlag; 2012, p. 265–280.Google Scholar

Nistal, M., Paniagua, R., Gonzalez-Peramato, P.. Nonneoplastic diseases of the testis. In: Bostwick, D.G., Cheng, L., editors, Urologic Surgical Pathology, 3rd edn. Philadelphia, PA: Elsevier Saunders; 2014, p. 560–735.Google Scholar

Cools, M., Stoop, H., Kersemaekers, A.M., et al. Gonadoblastoma arising in undifferentiated gonadal tissue within dysgenetic gonads. J Clin Endocrinol Metab 2006; 91: 2404–2413.Google Scholar

Modi, D.N., Sane, S., Bhartiya, D.. Accelerated germ cell apoptosis in sex chromosome aneuploid fetal human gonads. Mol Hum Reprod 2003; 9: 219–225.Google Scholar

Ogata, T., Matsuo, N.. Turner syndrome and female sex chromosome aberrations: deduction of the principal factors involved in the development of clinical features. Hum Genet 1995; 95: 607–629.Google Scholar

Bispo, A.V., Dos Santos, L.O., Burégio-Frota, P., et al. Effect of chromosome constitution variations on the expression of Turner phenotype. Genet Mol Res 2013; 12: 4243–4250.Google Scholar

Held, K.R., Kerber, S., Kaminsky, E., et al. Mosaicism in 45,X Turner syndrome: does survival in early pregnancy depend on the presence of two sex chromosomes? Hum Genet 1992; 88: 288–294.Google Scholar

Zelaya, G., López Marti, J.M., Marino, R., et al. Gonadoblastoma in patients with Ullrich-Turner syndrome. Pediatr Dev Pathol 2015; 18: 117–121.Google Scholar

Chevalier, N., Letur, H., Lelannou, D., et al; French Study Group for Oocyte Donation. Materno-fetal cardiovascular complications in Turner syndrome after oocyte donation: insufficient prepregnancy screening and pregnancy follow-up are associated with poor outcome. J Clin Endocrinol Metab 2011; 96: E260–E267.Google Scholar

Kanakatti Shankar, R., Inge, T.H., Gutmark-Little, I., et al. Oophorectomy versus salpingo-oophorectomy in Turner syndrome patients with Y-chromosome material: clinical experience and current practice patterns assessment. J Pediatr Surg 2014; 49: 1585–1588.Google Scholar

Huang, H., Wang, C.Q., Tian, Q.J.. Clinical features and management of 33 patients with 46,XX pure gonadal dysgenesis. Gynecol Endocrinol 2016; 32: 995–998.Google Scholar

King, T.F., Conway, G.S.. Swyer syndrome. Curr Opin Endocrinol Diabetes Obes 2014; 21: 504–510.Google Scholar

Andonova, S., Robeva, R., Sirakov, M., et al. A novel SRY gene mutation p.F109 L in a 46,XY female with complete gonadal dysgenesis. Sex Dev 2015; 9: 333–337.CrossRefGoogle Scholar

Tagliarini, E.B., Assumpcao, J.G., Scolfaro, M.R., et al. Mutations in SRY and WT1 genes required for gonadal development are not responsible for XY partial gonadal dysgenesis. Braz J Med Res 2005; 38: 17–25.Google Scholar

Werner, R., Mönig, I., August, J., et al. Novel insights into 46,XY disorders of sex development due to NR5A1 gene mutation. Sex Dev 2015; 9: 260–268.CrossRefGoogle ScholarPubMed

Nistal, M., Paniagua, R., González-Peramato, P., et al. Perspectives in pediatric pathology, Chapter 5: Gonadal dysgenesis. Pediatr Dev Pathol 2015; 18: 259–278.CrossRefGoogle ScholarPubMed

Guercio, G., Costanzo, M., Grinspon, R.P., et al. Fertility issues in disorders of sex development. Endocrinol Metab Clin North Am 2015; 44: 867–881.Google Scholar

Michala, L., Goswami, D., Creighton, S.M., et al. Swyer syndrome: presentation and outcomes. BJOG 2008; 115: 737–741.CrossRefGoogle ScholarPubMed

Tosson, H., Rose, S.R., Gartner, L.A.. Description of children with 45,X/46,XY karyotype. Eur J Pediatr 2012; 171: 521–529.Google Scholar

Andrade, J.G., Guerra-Júnior, G., Maciel-Guerra, A.T.. 46,XY and 45,X/46,XY testicular dysgenesis: similar gonadal and genital phenotype, different prognosis. Arq Bras Endocrinol Metabol 2010; 54: 331–334.CrossRefGoogle Scholar

Ribeiro Scolfaro, M., Aparecida Cardinalli, I., Gabas Stuchi-Perez, E., et al. Morphometry and histology of gonads from 13 children with dysgenetic male pseudohermaphroditism. Arch Pathol Lab Med 2001; 125: 652–656.Google Scholar

Slowikoska-Hilczer, J., Szarras-Czapnik, M., Kula, K.. Testicular pathology in 46,XY dysgenetic male pseudohermaphroditism: an approach to pathogenesis of testis cancer. J Androl 2001; 22: 781–792.CrossRefGoogle Scholar

Shalaby, M.M., Kurkar, A., Zarzour, M.A., et al. The management of the persistent Müllerian duct syndrome. Arab J Urol 2014; 12: 239–244.Google Scholar

Imbeaud, S., Belville, C., Messika-Zeitoun, L., et al. A 27 base-pair deletion of the anti-müllerian type II receptor gene is the most common cause of the persistent müllerian duct syndrome. Hum Mol Genet 1996; 5: 1269–1277.Google Scholar

Belville, C., Maréchal, J.D., Pennetier, S., et al. Natural mutations of the anti-Mullerian hormone type II receptor found in persistent Mullerian duct syndrome affect ligand binding, signal transduction and cellular transport. Hum Mol Genet 2009; 18: 3002–3013.Google Scholar

Krstic, Z.D., Smoljanic, Z., Vukanic, D., et al. True hermaphroditism: 10 years’ experience. Pediatr Surg Int 2000; 16: 580–583.Google Scholar

Aaronson, I.A.. True hermaphroditism: a review of 41 cases with observations on testicular histology and function. Br J Urol 1985; 57: 775–779.Google Scholar

Wiersma, R., Ramdial, P.K.. The gonads of 111 South African patients with ovotesticular disorder of sex differentiation. J Pediatr Surg 2009; 44: 556–560.Google Scholar

Yordam, N., Alikasifoglu, A., Kandemir, N., et al. True hermaphroditism: clinical features, genetic variants and gonadal histology. J Pediatr Endocrinol Metab 2001; 14: 421–427.Google Scholar

Wettasinghe, K.T., Sirisena, N.D., Andraweera, P.H., et al. A case series of five srilankan patients with ovotesticular disorder of sex development. Clin Pediatr Endocrinol 2012; 21: 69–73.Google Scholar

Morel, Y., Rey, R., Teinturier, C., et al. An etiological diagnosis of male sex ambiguity: a collaborative study. Eur J Pediatr 2002; 161: 49–59.Google Scholar

Kolon, T.F., Ferrer, F.A., Mckenna, P.H.. Clinical and molecular analysis of XX sex reversed patients. J Urol 1998; 160: 1169–1172.Google Scholar

Kojima, Y., Hayashi, Y., Mizuno, K., et al. Up-regulation of SOX9 in human sex-determining region on the Y chromosome (SRY)-negative XX males. Clin Endocrinol (Oxf) 2008; 68: 791–799.Google Scholar

Ledig, S., Hiort, O., Wünsch, L., et al. Partial deletion of DMRT1 causes 46,XY ovotesticular disorder of sexual development. Eur J Endocrinol 2012; 167: 119–124.CrossRefGoogle ScholarPubMed

Tomaselli, S., Megiorni, F., De Bernardo, C., et al. Syndromic true hermaphroditism due to an R-spondin1 (RSPO1) homozygous mutation. Hum Mutat 2008; 29: 220–226.Google Scholar

Jingde, Z., Xin, X., Entan, G., et al. Surgical treatment of hermaphroditism: experience with 25 cases. Ann Plast Surg 2009; 63: 543–551.CrossRefGoogle ScholarPubMed

Schultz, B.A., Roberts, S., Rodgers, A., et al. Pregnancy in true hermaphrodites and all male offspring to date. Obstet Gynecol 2009; 113: 534–536.Google Scholar

Nistal, M., Paniagua, R., González-Peramato, P., et al. Perspectives in pediatric pathology, Chapter 6: Male undermasculinization. Pediatr Dev Pathol 2015; 18: 279–296.Google Scholar

Richter-Unruh, A., Martens, J.W., Verhoef-Post, M., et al. Leydig cell hypoplasia: cases with new mutations, new polymorphisms and cases without mutations in the luteinizing hormone receptor gene. Clin Endocrinol (Oxf) 2002; 56: 103–112.Google Scholar

Mendonca, B.B., Costa, E.M., Belgorosky, A., et al. 46,XY DSD due to impaired androgen production. Best Pract Res Clin Endocrinol Metab 2010; 24: 243–262.Google Scholar

Brinkmann, AO. Molecular basis of androgen insensitivity. Mol Cell Endocrinol 2001; 179: 105–109.Google Scholar

Regadera, J., Martinez-García, F., Paniagua, R., et al. Androgen insensitivity syndrome: an immunohistochemical, ultrastructural, and morphometric study. Arch Pathol Lab Med 1999; 123: 225–234.Google Scholar

Rutgers, J.L., Scully, R.E.. The androgen insensitivity syndrome (testicular feminization): a clinicopathologic study of 43 cases. Int J Gynecol Pathol 1991; 10: 126–144.Google Scholar

Imperato-McGinley, J., Guerrero, L., Gautier, T., et al. Steroid 5alpha-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science 1974; 186(4170): 1213–1215.Google Scholar

Okeigwe, I., Kuohung, W.. 5-Alpha reductase deficiency: a 40-year retrospective review. Curr Opin Endocrinol Diabetes Obes 2014; 21: 483–487.Google Scholar

Ferlay, J., Soerjomataram, I., Ervik, M., et al. GLOBOCAN2012v1.0. Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Cited Dec 2013. Lyon, France: International Agency for Research on Cancer, 2013. http://globocan.iarc.fr (accessed May 2018).Google Scholar

Ulbright, T.M., Young, R.H.. Primary mucinous tumors of the testis and paratestis: a report of nine cases. Am J Surg Pathol 2003; 27: 1221–1228.Google Scholar

Funada, S., Yoshida, T., Ito, M., Kono, F., Segawa, T.. Primary borderline mucinous tumors of the testis: a case report and literature review. Case Rep Oncol Med 2015; 2015: 863745.Google Scholar

Jones, M.A., Young, R.H., Srigley, J.R., Scully, R.E.. Paratesticular serous papillary carcinoma: a report of six cases. Am J Surg Pathol 1995; 19: 1359–1365.Google Scholar

Becerra, P., Isaac, M.A., Marquez, B., et al. Papillary serous carcinoma of the tunica vaginalis testis. Pathol Res Pract 2000; 196: 781–782.Google Scholar

Remelle, W., Kaiserling, E., Zerban, U., et al. Serous papillary cystic tumor of borderline malignancy with focal carcinoma arising in testis: case report with immunohistochemical and ultrastructural observations. Hum Pathol 1992; 23: 75–79.Google Scholar

Delahunt, B., Nacey, J.N.. Ovarian-type papillary serous cystadenocarcinoma of the testis. Br J Urol 1996; 77: 156–157.Google Scholar

Guarch, R., Rivas, A., Puras, A., Pesce, C.. Papillary serous carcinoma of ovarian type of the testis with borderline differentiation. Histopathology 2005; 46: 587–599.Google Scholar

Maruschke, M., Schmidt, W., Casper, J., Hakenberg, O.W.. Ovarian type surface epithelial carcinoma of the testis with delayed metastatic spread. Urol Int 2008; 81: 119–121.Google Scholar

Young, R.H., Scully, R.E.. Testicular and paratesticular tumors and tumor-like lesions of ovarian common epithelial and mullerian types: a report of four cases and review of the literature. Am J Clin Pathol 1986; 86: 146–152.Google Scholar

McClure, R.F., Keeney, G.L., Sebo, T.J., Cheville, J.C.. Serous borderline tumor of the paratestis: a report of seven cases. Am J Surg Pathol 2001; 25: 373–378.Google Scholar

Brito, C.G., Bloch, T., Foster, R.S., Bihrle, R.. Testicular papillary cystadenomatous tumor of low malignant potential: a case report and discussion of the literature. J Urol 1988; 139: 378–379.Google Scholar

Axiotis, C.A.. Intratesticular serous papillary cystadenoma of low malignant potential: an ultrastructural and immunohistochemical study suggesting Mullerian differentiation. Am J Surg Pathol 1988; 12: 56–63.Google Scholar

De Nictolis, M., Tommasoni, S., Fabris, G., Prat, J.. Intratesticular serous cystadenoma of borderline malignancy: a pathological, histochemical and DNA content study of a case with long-term follow-up. Virch Arch A Pathol Anat 1993; 423: 221–225.Google Scholar

Maruyana, H., Ohyama, N., Hosokawa, Y., et al. Serous borderline tumor of the paratestis. Case report. Pathol Int 2008; 58: 311–316.Google Scholar

McCluggage, W.G., Shah, V., Nott, C., et al. Cystadenoma of spermatic cord resembling ovarian serous epithelial tumour of low malignant potential: immunohistochemical study suggesting Mullerian differentiation. Histopathology 1996; 28: 77–80.Google Scholar

Nistal, M., Revestido, R., Paniagua, R.. Bilateral mucinous cystadenocarcinoma of the testis and epididymis. Arch Pathol Lab Med 1992; 116: 1360–1363.Google Scholar

Uschuplich, V., Hilsenbeck, J.R., Velasco, C.R.. Paratesticular mucinous cystadenoma arising from an oviduct-like mullerian remnant: a case report and review of the literature. Arch Pathol Lab Med 2006; 130: 1715–1717.Google Scholar

Elliott, J.E., Klein, J.R.H., Drachenberg, D.E.. Primary testicular mucinous neoplasms: case report and literature review. Can Urol Assoc J 2010; 4: E112–E115.Google Scholar

Azuma, T., Matayoshi, Y., Nagase, Y.. Primary mucinous adenocarcinoma of the testis. Case Report Med 2012; 2012: 685946.Google Scholar

Cohen, M., Shawis, R., Evans, C.. Paratesticular Mullerian-type papillary serous tumor in a child. Pediatr Dev Pathol 2009; 12: 297–300.Google Scholar

Caroassai Grisanti, S., Bigazzi, B., Raspollini, M.R., et al. Conservative treatment of serous borderline paratesticular tumor in a pediatric patient. Urology 2016; 89: 123–125.Google Scholar

Köbel, M., Kalloger, S.E., Boyd, N., et al. Ovarian carcinoma subtypes are different diseases: implications for biomarker studies. PLoS Med 2008; 5: e232.Google Scholar

Mackenzie, R., Talhouk, A., Eshragh, S., et al. Morphological and molecular characteristics of mixed epithelial ovarian carcinomas. Am J Surg Pathol 2015; 39: 1548–1557.Google Scholar

Kurman, R.J., Shin, I.M.. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol 2010; 34: 433–443.Google Scholar

Kurman, R.J., Shin, I.M.. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer: shifting the paradigm. Hum Pathol 2011; 42: 918–931.Google Scholar

Arends, M.J., White, E.S., Whitelaw, C.B.A.. Models of endometriosis and their utility in studying progression to ovarian clear cell carcinoma. J Pathol 2016; 238: 185–196.Google Scholar

Sato, N., Tsuboda, H., Nishida, M., et al. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Cancer Res 2000; 60: 7052–7056.Google Scholar

Seidman, J.D., Yemelyanova, A., Zaino, R.J., Kurman, R.J.. The fallopian tube–peritoneal junction: a potential site of carcinogenesis. Int J Gynecol Pathol 2011; 30: 4–11.Google Scholar

Rabban, J.T., Karnezis, A.N., Zaloudek, C.J.. Junctional epithelial zones of the fallopian tube: cancer hotspots? Int J Gynecol Pathol 2011; 30: 1–3.Google Scholar

Piek, J.M., van Diest, P.J., Zweemer, R.P., et al. Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer. J Pathol 2001; 195: 451–456.Google Scholar

Swerdlow, M.. Mesothelioma of the pelvic peritoneum resembling papillary cystadenocarcinoma of the ovary: case report. Am J Obstet Gynecol 1959; 77: 197–200.Google Scholar

Amin, M.B.. Selected other problematic testicular and paratesticular lesions: rete testis neoplasms and pseudotumors, mesothelial lesions and secondary tumors. Mod Pathol 2005; 18: S131–S145.Google Scholar

Shimbo, M., Araki, K., Kaibuchi, T., Kuramochi, H., Mori, I.. Mucinous cystadenoma of the testis. J Urol 2004; 172: 146–147.Google Scholar

Bürger, T., Schildhaus, H.U., Inniger, R., et al. Ovarian-type epithelial tumours of the testis: immunohistochemical and molecular analysis of two serous borderline tumours of the testis. Diagn Pathol 2015; 10: 118.Google Scholar

Scully, R.E., Young, R.H., Clement, P.B.. Tumours of the ovary, maldeveloped gonads, fallopian tube and broad legament. In: Rosai, J., Sobin, L.H., editors, Atlas of Tumor Pathology, 3rd edn., Vol 2. Washington, DC: Armed Forces Institute of Pathology; 1998.Google Scholar

Longacre, T.A., McKenney, J.K., Tazelaar, H.D., et al. Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or = 5-year) follow-up. Am J Surg Pathol 2005; 29: 707–723.Google Scholar

Kosmehl, H., Langbein, L., Kiss, F.. Papillary serous cystoadenoma of the testis. Int Urol Nephrol 1989; 21: 169–174.Google Scholar

Olla, L., Di Naro, N., Puliga, G., et al. Intraparenchymal serous papillary cystadenoma of the testis: a case report. Pathologica 2013; 105: 15–17.Google Scholar

Algaba, F., Mikuz, G., Boccon-Gibod, L., et al. Pseudoneoplastic lesions of the testids and paratesticular structures. Virchows Arch 2007; 451: 987–997.Google Scholar

Morice, P., Uzan, C., Fauvet, R., et al. Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence. Lancet Oncol 2012; 13: e103–e115.Google Scholar

Karlsen, N.M., Karlsen, M.A., Høgdall, E., et al. Relapse and disease specific survival in 1143 Danish women diagnosed with borderline ovarian tumours (BOT). Gynecol Oncol 2016; 142(1): 50–53.Google Scholar

Malpica, A., Wong, K.K.. The molecular pathology of ovarian serous borderline tumors. Ann Oncol 2016; 27(Suppl 1): i16–i19.Google Scholar

Parker, R.L., Clement, P.B., Chercover, D.J., Sornarajah, T., Gilks, C.B.. Early recurrence of ovarian serous borderline tumor as high-grade carcinoma: a report of two cases. J Gynecol Pathol 2004; 23: 265–272.Google Scholar

Tropé, C.G., Kaern, J., Davidson., B. Borderline ovarian tumours. Best Pract Res Clin Obstet Gynaecol 2012; 26: 325–336.Google Scholar

Bell, D.A., Scully, R.E.. Ovarian serous borderline tumors with stromal microinvasion: a report of 21 cases. Hum Pathol 1990; 21: 397–403.Google Scholar

McKenney, J.K., Balzer, B.L., Longacre, T.A.. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion. Am J Surg Pathol 2006; 30: 1209–1221.Google Scholar

Prat, J., De Nictolis, M.. Serous borderline tumors of the ovary: a long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion. Am J Surg Pathol 2002; 26: 1111–1128.Google Scholar

Park, J.Y., Kim, D.Y., Kim, J.H., et al. Micropapillary pattern in serous borderline ovarian tumors: does it matter? Gynecol Oncol 2011; 123: 511–516.Google Scholar

Chang, S.J., Ryu, H.S., Chang, K.H., Yoo, S.C., Yoon, J.H.. Prognostic significance of the micropapillary pattern in patients with serous borderline ovarian tumors. Acta Obstet Gynecol Scand 2008; 87: 476–481.Google Scholar

Eichhorn, J.H., Bell, D.A., Young, R.H., Scully, R.E.. Ovarian serous borderline tumors with micropapillary and cribriform patterns: a study of 40 cases and comparison with 44 cases without these patterns. Am J Surg Pathol 1999; 23: 397–409.Google Scholar

Wachter, D.L., Wunsch, P.H., Hartmann, A., Agaimy, A.. Adenomatoid tumors of the female and the male genital tract: a comparative clinicopathological and immunohistohemical analysis of 47 cases emphasizing their site-specific morphologic diversity. Virchows Arch 2011; 458: 593–602.Google Scholar

Sangoi, A.R., McKenney, J.K., Schwartz, E.J., et al. Adenomatoid tumors of the female and the male genital tracts: a clinicopathological and immunohistochemical study of 44 cases. Mod Pathol 2009; 22: 1228–1235.Google Scholar

Mutter, G.L., Prat, J.. Pathology of the Female Reproductive Tract, 3rd edn. Dordrecht: Elsevier; 2014.Google Scholar

Colombo, N., Creutzberg, C., Amant, F., et al.; ESMO-ESGO-ESTRO Endometrial Consensus Conference Working Group. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up. Int J Gynecol Cancer 2016; 26: 2–30.Google Scholar

Lee, Y.J., Lee, M.Y., Ruan, A., et al. Multipoint Kras oncogene mutations potentially indicate mucinous carcinoma on the entire spectrum of mucinous ovarian neoplasms. Oncotarget 2016; 7: 82097–82103.Google Scholar

Perren, T.J.. Mucinous epithelial ovarian carcinoma. Ann Oncol 2016; 27(Suppl 1): i53–i57.Google Scholar

Ahmed, R., Din, H.U., Hashmi, S.N., Muhammad, I.. Sarcoma-like mural nodule in a borderline mucinous tumour of ovary. J Coll Physicians Surg Pak 2016; 26: 435–437.Google Scholar

Lee, K.R., Tavassoli, F.A., Prat, J., et al. Tumours of the ovary and peritoneum: surface epithelial-stromal tumours. In: Tavassoli, F.A., Devilee, P., editors, World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon, France: IARC; 2003.Google Scholar

Numakura, K., Tsuchiya, N., Tsuruta, H., et al. A case of intratesticular endometrioid papillary cystoadenocarcinoma. Jpn J Clin Oncol 2011; 41: 674–676.Google Scholar

Uzan, C., Dufeu-Lefebvre, M., Fauvet, R., et al. Management and prognosis of clear cell borderline ovarian tumor. Int J Gynecol Cancer 2012; 22: 993–999.Google Scholar

Anglesio, M.S., Carey, M.S., Köbel, M., Mackay, H., Huntsman, D.G.; Vancouver Ovarian Clear Cell Symposium Speakers. Clear cell carcinoma of the ovary: a report from the first Ovarian Clear Cell Symposium, June 24th, 2010. Gynecol Oncol 2011; 121: 407–415.Google Scholar

del Carmen, M.G., Birrer, M., Schorge, J.O.. Clear cell carcinoma of the ovary: a review of the literature. Gynecol Oncol 2012; 126: 481–490.Google Scholar

Cai, K.Q., Albarracin, C., Rosen, D., et al. Microsatellite instability and alteration of the expression of hMLH1 and hMSH2 in ovarian clear cell carcinoma. Hum Pathol 2004; 35: 552–559.Google Scholar

Nakonechny, Q.B., Gilks, C.B.. Ovarian cancer in hereditary cancer susceptibility syndromes. Surg Pathol Clin 2016; 9: 189–199.Google Scholar

Takano, M., Kikuchi, Y., Yaegashi, N., et al. Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging. Br J Cancer 2006; 94: 1369–1374.Google Scholar

Hoskins, P.J., Le, N., Gilks, B., et al. Low-stage ovarian clear cell carcinoma: population-based outcomes in British Columbia, Canada, with evidence for a survival benefit as a result of irradiation. J Clin Oncol 2012; 30: 1656–1662.Google Scholar

Lee, Y.Y., Kim, T.J., Kim, M.J., et al. Prognosis of ovarian clear cell carcinoma compared to other histological subtypes: a meta-analysis. Gynecol Oncol 2011; 122: 541–547.Google Scholar

Pectasides, D., Pectasides, E., Psyrri, A., Economopoulos, T.. Treatment issues in clear cell carcinoma of the ovary: a different entity? Oncologist 2006; 11: 1089–1094.Google Scholar

Tulunay, O., Gogus, C., Baltaci, S., et al. Clear cell adenocarcinoma of the tunica vaginalis of the testis with an adjcent uterus-like tissue. Pathol Int 2004; 54; 641–647.Google Scholar

Brenner, F.. Das oophoroma folliculare. Frankfurt Z Path 1907; 1: 150–171.Google Scholar

Kondi-Pafiti, A., Kairi-Vassilatou, E., Iavazzo, Ch., et al. Clinicopathological features and immunoprofile of 30 cases of Brenner ovarian tumors. Arch Gynecol Obstet 2012; 285: 1699–1702.Google Scholar

Kuhn, E., Ayhan, A., Shih, I.M., Seidman, J.D., Kurman, R.J.. Ovarian Brenner tumour: a morphologic and immunohistochemical analysis suggesting an origin from fallopian tube epithelium. Eur J Cancer 2013; 49: 3839–3849.Google Scholar

Roma, A.A., Masand, R.P.. Different staining patterns of ovarian Brenner tumor and the associated mucinous tumor. Ann Diagn Pathol 2015; 19: 29–32.Google Scholar

Cuatrecasas, M., Erill, N., Musulen, E., et al. K-ras mutations in nonmucinous ovarian epithelial tumors: a molecular analysis and clinicopathologic study of 144 patients. Cancer 1998; 15(82): 1088–1095.Google Scholar

Caccamo, D., Socias, M., Trichet, C.. Malignant Brenner tumor of the testis and epididymis. Arch Pathol Lab Med 1991; 115: 524–527.Google Scholar

Rambau, P.F., McIntyre, J.B., Taylor, J., et al. Morphologic reproducibility, genotyping, and immunohistochemical profiling do not support a category of seromucinous carcinoma of the ovary. Am J Surg Pathol 2017; 41(5): 1.Google Scholar

Scholz, B., Beckert, M., Mordstein, V., et al. Seromucinous borderline tumor of the testis: a case report. Hum Pathol 2017; 60: 188–191.Google Scholar

Kurman, R.J., Carcangiu, M.L., Herrington, C.S., Young, R.H.. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Female Reproductive Organs. Lyon, France: IARC Press; 2014.Google Scholar

Moch, H., Humphrey, P.A., Ulbright, T.M., Reuter, V.E.. WHO Classification of Tumours of the Urinary System and Male Genital Organs, 4th edn., Vol. 8. Lyon, France: IARC Press; 2016.Google Scholar

Mostofi, F.K., Sesterhenn, I.A.. Pathology of germ cell tumors of the testes. Prog Clin Biol Res 1985; 203: 1–34.Google Scholar

Bredael, J.J., Vugrin, D., Whitmore, W.T. Jr. Autopsy findings in 154 patients with germ cell tumors of the testis. Cancer 1982; 50: 548–551.Google Scholar

Czaja, J.T., Ulbright, T.M.. Evidence for the transformation of seminoma to yolk sac tumor, with histogenetic considerations. Am J Clin Pathol 1992; 97: 468–477.Google Scholar

Monaghan, P., Raghavan, D., Neville, M.. Ultrastructure of xenografted human germ cell tumors. Cancer 1982; 49: 683–697.Google Scholar

Geurts van Kessel, A., Suijkerbuijk, R.F., Sinke, R.J., et al. Molecular cytogenetics of human germ cell tumours: i(12p) and related chromosomal anomalities. Eur Urol 1993; 23: 23–28.Google Scholar

Norris, H.J., Zirkin, H.J., Benson, W.L.. Immature (malignant) teratoma of the ovary: a clinical and pathologic study of 58 cases. Cancer 1976; 37: 2359–2372.Google Scholar

Yanai-Inbar, I., Scully, R.E.. Relation of ovarian dermoid cysts and immature teratomas: an analysis of 350 cases of immature teratoma and 10 cases of dermoid cyst with microscopic foci of immature tissue. Int J Gynecol Pathol 1987; 6: 203–212.Google Scholar

Baker, B.A., Frickey, L., Yu, I.T., et al. DNA content of ovarian immature teratomas and malignant germ cell tumors. Gynecol Oncol 1998; 71: 14–18.Google Scholar

Reyes, A., Moran, C.A., Suster, S., et al. Neuroendocrine carcinomas (carcinoid tumor) of the testis: a clinicopathologic and immunohistochemical study of ten cases. Am J Surg Pathol 2003; 120: 182–187.Google Scholar

Merino, J., Zuluaga, A., Gutierrez-Tejero, F., et al. Pure testicular carcinoid associated with intratubular germ cell neoplasia. J Clin Pathol 2005; 58: 1331–1333.Google Scholar

Burke, A.P., Mostofi, F.K.. Placental alkaline phosphatase immunohistochemistry of intratubular malignant germ cells and associated testicular germ cell tumors. Hum Pathol 1988; 19: 663–670.Google Scholar

Hustin, J., Collette, J., Franchimont, P.. Immunohistochemical demonstration of placental alkaline-phosphatase in various states of testicular development and in germ-cell tumors. Int J Androl 1987; 10: 29–35.Google Scholar

Jacobsen, G.K., Norgaard-Pedersen, B.. Placental alkaline phosphatase in testicular germ cell tumours and in carcinoma-in-situ of the testis: an immunohistochemical study. Acta Pathol Microbiol Immunol Scand A 1984; 92: 323–329.Google Scholar

Loftus, B.M., Gilmartin, L.G., O’Brien, M.J., et al. Intratubular germ cell neoplasia of the testis: identification by placental alkaline phosphatase immunostaining and argyrophilic nucleolar organizer region quantification. Hum Pathol 1990; 21: 941–948.Google Scholar

Krabbe, S., Skakkebaek, N.E., Berthelsen, J.G., et al. High incidence of undetected neoplasia in malescended testes. Lancet 1979; 1: 999–1000.Google Scholar

Jones, T.D., Ulbright, T.M., Eble, J.N., et al. OCT4 staining in testicular tumors: a sensitive and specific marker for seminoma and embryonal carcinoma. Am J Surg Pathol 2004; 28: 935–940.Google Scholar

Jones, T.D., Ulbright, T.M., Eble, J.N., et al. OCT4: a sensitive and specific biomarker for intratubular germ cell neoplasia of the testis. Clin Cancer Res 2004; 10(24): 8544–8547.Google Scholar

de Jong, J., Stoop, H., Dohle, G.R., et al. Diagnostic value of OCT3/4 for pre-invasive and invasive testicular germ cell tumours. J Pathol 2005; 206: 242–249.Google Scholar

Sung, M.T., Jones, T.D., Beck, S.D., et al. OCT4 is superior to CD30 in the diagnosis of metastatic embryonal carcinomas after chemotherapy. Hum Pathol 2006; 37: 662–667.Google Scholar

Rajpert-De Meyts, E., Skakkebaek, N.E.. Expression of the c-kit protein product in carcinoma-in-situ and invasive testicular germ cell tumours. Int J Androl 1994; 17: 85–92.Google Scholar

American Joint Committee on Cancer (AJCC); Amin, M.B, Edge, S, Greene, F, et al., editors, Staging Manual, 8th edn. London, UK: Springer Education; 2017.Google Scholar

Leroy, X., Augusto, D., Leteurtre, E., et al. CD30 and CD117 (c-kit) used in combination are useful for distinguishing embryonal carcinoma from seminoma. J Histochem Cytochem 2002; 50: 283–285.Google Scholar

Lau, S.K., Weiss, L.M., Chu, P.G.. D2-40 immunohistochemistry in the differential diagnosis of seminoma and embryonal carcinoma: a comparative immunohistochemical study with KIT (CD117) and CD30. Mod Pathol 2007; 20: 320–325.Google Scholar

Bode, P.K., Barghorn, A., Fritzsche, F.R., et al. MAGEC2 is a sensitive and novel marker for seminoma: a tissue microarray analysis of 325 testicular germ cell tumors. Mod Pathol 2011; 24: 829–835.Google Scholar

Cheng, L., Sung, M.T., Cossu-Rocca, P., et al. OCT4: biological functions and clinical applications as a marker of germ cell neoplasia. J Pathol 2007; 211: 1–9.Google Scholar

Looijenga, L.H., Stoop, H., de Leeuw, H.P., et al. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 2003; 63: 2244–2250.Google Scholar

Ulbright, T.M., Tickoo, S.K., Berney, D.M., et al. Best practices recommendations in the application of immunohistochemistry in testicular tumors: report from the International Society of Urologic Pathology Consensus Conference. Am J Surg Pathol 2014; 38: e35–e49.Google Scholar

Idrees, M., Saxena, R., Cheng, L., et al. Podoplanin, a novel marker for seminoma: a comparison study evaluating immunohistochemical expression of podoplanin and OCT3/4. Ann Diagn Pathol 2010; 14: 331–336.Google Scholar

Yu, H., Pinkus, G.S., Hornick, J.L.. Diffuse membranous immunoreactivity for podoplanin (D2-40) distinguishes primary and metastatic seminomas from other germ cell tumors and metastatic neoplasms. Am J Clin Pathol 2007; 128: 767–775.Google Scholar

de Jong, J., Stoop, H., Gillis, A.J., et al. Differential expression of SOX17 and SOX2 in germ cells and stem cells has biological and clinical implications. J Pathol 2008; 215: 21–30.Google Scholar

Nonaka, D.. Differential expression of SOX2 and SOX17 in testicular germ cell tumors. Am J Clin Pathol 2009; 131: 731–736.Google Scholar

Cheville, J.C., Rao, S., Iczkowski, K.A., et al. Cytokeratin expression in seminoma of the human testis. Am J Clin Pathol 2000; 113: 583–588.Google Scholar

Niehans, G.A., Manivel, J.C., Copland, G.T., et al. Immunohistochemistry of germ cell and trophoblastic neoplasms. Cancer 1988; 62: 1113–1123.Google Scholar

Berney, D.M., Shamash, J., Pieroni, K., et al. Loss of CD30 expression in metastatic embryonal carcinoma: the effects of chemotherapy? Histopathology 2001; 39: 382–385.Google Scholar

Pallesen, G., Hamilton-Dutoit, S.J.. Ki-1 (CD30) antigen is regularly expressed in tumor cells of embryonal carcinoma. Am J Pathol 1988; 133: 446–450.Google Scholar

Hittmair, A., Rogatsch, H., Hobisch, A., et al. CD30 expression in seminoma. Hum Pathol 1996; 27: 1166–1171.Google Scholar

Ferreiro, J.A.. Ber-H2 expression in testicular germ cell tumors. Hum Pathol 1994; 25(5): 522–524.Google Scholar

Gopalan, A., Dhall, D., Olgac, S., et al. Testicular mixed germ cell tumors: a morphological and immunohistochemical study using stem cell markers, OCT3/4, SOX2 and GDF3, with emphasis on morphologically difficult-to-classify areas. Mod Pathol 2009; 22: 1066–1074.Google Scholar

McNamee, T., Damato, S., McCluggage, W.G.. Yolk sac tumours of the female genital tract in older adults derive commonly from somatic epithelial neoplasms: somatically derived yolk sac tumours. Histopathology 2016; 69: 739–751.Google Scholar

Eglen, D.E., Ulbright, T.M.. The differential diagnosis of yolk sac tumor and seminoma. Usefulness of cytokeratin, alpha-fetoprotein, and alpha-1-antitrypsin immunoperoxidase reactions. Am J Clin Pathol 1987; 88: 328–332.Google Scholar

Kao, C.S., Idrees, M.T., Young, R.H., et al. Solid pattern yolk sac tumor in testicular germ cell tumors: a morphologic and immunohistochemical study of 52 cases. Am J Surg Pathol 2012; 36: 360–367.Google Scholar

Ota, S., Hishinuma, M., Yamauchi, N., et al. Oncofetal protein glypican-3 in testicular germ-cell tumor. Virchows Arch 2006; 449: 308–314.Google Scholar

Zynger, D.L., Dimov, N.D., Luan, C., et al. Glypican 3: a novel marker in testicular germ cell tumors. Am J Surg Pathol 2006; 30: 1570–1575.Google Scholar

Zynger, D.L., McCallum, J.C., Luan, C., et al. Glypican 3 has a higher sensitivity than alpha-fetoprotein for testicular and ovarian yolk sac tumour: immunohistochemical investigation with analysis of histological growth patterns. Histopathology 2010; 56: 750–757.Google Scholar

Cao, D., Li, J., Guo, C.C., et al. SALL4 is a novel diagnostic marker for testicular germ cell tumors. Am J Surg Pathol 2009; 33: 1065–1077.Google Scholar

Alvarado-Cabrero, I., Hernández-Toriz, N., Paner, G.P.. Clinicopathologic analysis of choriocarcinoma as a pure or predominant component of germ cell tumor of the testis. Am J Surg Pathol 2014; 38(1): 111–118.Google Scholar

Miettinen, M., Wang, Z., McCue, P.A., et al. SALL4 expression in germ cell and non germ-cell tumors: a systematic immunohistochemical study of 3215 cases. Am J Surg Pathol 2014; 38: 410–420.Google Scholar

Looijenga, L.H.. Human testicular (non)seminomatous germ cell tumours: the clinical implications of recent pathobiological insights. J Pathol 2009; 218: 146–162.Google Scholar

Gopalan, A., Dhall, D., Olgac, S., et al. Testicular mixed germ cell tumors: a morphological and immunohistochemical study using stem cell markers OCT3/4, SOX2, and CDF3 with emphasis on morphologically difficult to classify areas. Mod Pathol 2009; 22: 1066–1074.Google Scholar

Mikuz, G.. Clinical Pathology of Urologic Tumors. London, UK: Informa Health Care; 2006.Google Scholar

Kraggerud, S.M., Berner, A., Bryne, M., et al. Spermatocytic seminoma as compared to classical seminoma: an immunohistochemical and DNA flow cytometric study. APMIS 1999; 107: 297–302.Google Scholar

Kato, K., Ijiri, R., Tanaka, Y., et al. Testicular immature teratoma with primitive neuroectodermal tumor in early chilhood. J Urol 2000; 164: 2068–2069.Google Scholar

Henley, J.D., Young, R.H., Ulbright, T.M.. Malignant Sertoli cell tumors of the testis: a study of 13 examples of a neoplasm frequently misinterpreted as seminoma. Am J Surg Pathol 2002; 26: 541–550.Google Scholar

Esber, C.M., Shabsigh, A., Zynger, D.L.. Sclerosing Sertoli cell tumor without expression of typical sex cord stromal tumor markers: case report and literature review. Pathol Res Pract 2012; 208: 121–125.Google Scholar

Young, R.H.. Sex cord-stromal tumors of the ovary and testis: their similarities and differences with consideration of selected problems. Mod Pathol 2005; 18(Suppl 2): S81–S98.Google Scholar

Proppe, K.H., Dickersin, G.R.. Large-cell calcifying Sertoli cell tumor of the testis: light microscopic and ultrastructural study. Hum Pathol 1982; 13: 1109–1114.Google Scholar

Plata, C., Algaba, F., Andújaret, M., et al. Large cell calcifying Sertoli cell tumour of the testis. Histopathology 1995; 26: 255–259.Google Scholar

Kratzer, S.S., Ulbright, T.M., Talerman, A., et al. Large cell calcifying Sertoli cell tumor of the testis: contrasting features of six malignant and six benign tumors and a review of the literature. Am J Surg Pathol 1997; 21: 1271–1280.Google Scholar

De Raeve, H., Schoonooghe, P., Wibowo, R., et al. Malignant large cell calcifying Sertoli cell tumor of the testis. Pathol Res Pract 2003; 199: 113–117.Google Scholar

Ulbright, T.M., Amin, M.B., Young, R.H.. Intratubular large cell hyalinizing sertoli cell neoplasia of the testis: a report of 8 cases of a distinctive lesion of the Peutz-Jeghers syndrome. Am J Surg Pathol 2007; 31: 827–835.Google Scholar

Ros, P., Nistal, M., Alonso, M., et al. Sertoli cell tumour in a boy with Peutz–Jeghers syndrome. Histopathology 1999; 34: 84–86.Google Scholar

Scully, R.E.. Sex cord tumor with annular tubules a distinctive ovarian tumor of the Peutz-Jeghers syndrome. Cancer 1970; 25: 1107–1121.Google Scholar

Young, R.H., Welch, W.R., Dickersin, G.R., et al. Ovarian sex cord tumor with annular tubules: review of 74 cases including 27 with Peutz-Jeghers syndrome and four with adenoma malignum of the cervix. Cancer 1982; 50: 1384–1402.Google Scholar

Ramaswamy, G., Jagadha, V., Tchertkoff, V.. A testicular tumor resembling the sex cord with annular tubules in a case of the androgen insensitivity syndrome. Cancer 1985; 55: 1607–1611.Google Scholar

Nosov, V., Park, S., Rao, J., et al. Non-Peutz-Jeghers syndrome associated ovarian sex cord tumor with annular tubules: a case report. Fertil Steril 2009; 92: 1497.e5–1497.e8.Google Scholar

Ishikawa, H., Kiyokawa, T., Takatani, T., et al. Giant multilocular sex cord tumor with annular tubules associated with precocious puberty. Am J Obstet Gynecol 2012; 206: e14–e16.Google Scholar

Han, Y., Li, S., Wu, L., Zhang, X., Cao, D.. Non-Peutz–Jeghers syndrome-associated ovarian sex cord tumor with annular tubules: report of a malignant case. J Obstet Gynaecol Res 2016; 42: 224–227.Google Scholar

Gracia, R., Nistal, M., Gallego, M.E., et al. Leydig cell tumor with pseudoprecocious puberty. An Esp Pediatr 1980; 13: 593–598.Google Scholar

O’Grady, M.J., McGrath, N., Quinn, F.M., et al. Spermatogenesis in a prepubertal boy. J Pediatr 2012; 161: 369–369.e1.Google Scholar

Colecchia, M., Nistal, M., Gonzalez-Peramato, P., et al. Leydig cell tumor and hyperplasia: a review. Anal Quant Cytol Histol 2007; 29: 139–147.Google Scholar

Santonja, C., Varona, C., Burgos, F.J., et al. Leydig cell tumor of testis with adipose metaplasia. Appl Pathol 1989; 7: 201–204.Google Scholar

Geminiani, J.J., Marshall, S.D., Ho, T.S., et al. Testicular Leydig cell tumor with metachronous lesions: outcomes after metastasis resection and cryoablation. Case Rep Urol 2015; 2015: 748495.Google Scholar

Young, R.H., Scully, R.E.. Ovarian Sertoli–Leydig cell tumors: a clinicopathological analysis of 207 cases. Am J Surg Pathol 1985; 9: 543–569.Google Scholar

Gagnon, S., Têtu, B., Silva, E.G., McCaughey, W.T.. Frequency of alpha-fetoprotein production by Sertoli-Leydig cell tumors of the ovary: an immunohistochemical study of eight cases. Mod Pathol 1989; 2: 63–67.Google Scholar

Zhang, H., Hao, J., Li, C.Y., et al. Large moderately-differentiated ovarian Sertoli-Leydig cell tumor in a 13-year-old female: a case report. Oncol Lett 2016; 11: 1110–1112.Google Scholar

Young, R.H., Scully, R.E.. Ovarian Sertoli–Leydig cell tumors with a retiform pattern: a problem in histopathologic diagnosis: a report of 25 cases. Am J Surg Pathol 1983; 7: 755–771.Google Scholar

Roth, L.M., Slayton, R.E., Brady, L.W., et al. Retiform differentiation in ovarian Sertoli–Leydig cell tumors: a clinicopathologic study of six cases from a Gynecologic Oncology Group study. Cancer 1985; 55: 1093–1098.Google Scholar

Rathi, M., Budania, S.K., Khalid, M., et al. Bilateral retiform variant of Sertoli Leydig cell tumour of ovary: an uncommon tumor with review of literature. J Midlife Health 2015; 6: 35–38.Google Scholar

Young, R.H., Prat, J., Scully, R.E.. Ovarian Sertoli–Leydig cell tumors with heterologous elements. I. Gastrointestinal epithelium and carcinoid: a clinicopathologic analysis of thirty-six cases. Cancer 1982; 50: 2448–2456.Google Scholar

Prat, J., Young, R.H., Scully, R.E.. Ovarian Sertoli–Leydig cell tumors with heterologous elements. II. Cartilage and skeletal muscle: a clinicopathologic analysis of twelve cases. Cancer 1982; 50: 2465–2475.Google Scholar

Oliva, E., Alvarez, T., Young, R.H.. Sertoli cell tumors of the ovary: a clinicopathologic and immunohistochemical study of 54 cases. Am J Surg Pathol 2005; 29: 143–156.Google Scholar

Mooney, E.E., Nogales, F.F., Tavassoli, F.A.. Hepatocytic differentiation in retiform Sertoli-Leydig cell tumors: distinguishing a heterologous element from Leydig cells. Hum Pathol 1999; 30: 611–617.Google Scholar

Zaloudek, C., Norris, H.J.. Sertoli–Leydig tumors of the ovary: a clinicopathologic study of 64 intermediate and poorly differentiated neoplasms. Am J Surg Pathol 1984; 8: 405–418.Google Scholar

Yu, D.C., Pathak, B., Vargas, S.O., et al. Congenital intra-abdominal bilateral juvenile granulosa cell tumors of the testis associated with constitutional loss of material from chromosome 4. Pediatr Dev Pathol 2011; 14: 224–227.Google Scholar

Alexiev, B.A., Alaish, S.M., Sun, C.C.. Testicular juvenile granulosa cell tumor in a newborn: case report and review of the literature. Int J Surg Pathol 2007; 15: 321–325.Google Scholar

Nistal, M., Lázaro, R., García, J., et al. Testicular granulosa cell tumor of the adult type. Arch Pathol Lab Med 1992; 116: 284–287.Google Scholar

Zhang, C., Ulbright, T.M.. Nuclear localization of β-catenin in Sertoli cell tumors and other sex cord-stromal tumors of the testis: an immunohistochemical study of 87 cases. Am J Surg Pathol 2015; 39: 1390–1394.Google Scholar

Irving, J.A., Alkushi, A., Young, R.H., et al. Cellular fibromas of the ovary: a study of 75 cases including 40 mitotically active tumors emphasizing their distinction from fibrosarcoma. Am J Surg Pathol 2006; 30: 929–938.Google Scholar

Ting, Y., Yang, L.I., Juan, Z., et al. Ovarian thecoma with massive pleural effusion in postmenopausal women: a case report. Mol Clin Oncol 2016; 4: 1003–1005.Google Scholar

Burandt, E., Young, R.H.. Thecoma of the ovary: a report of 70 cases emphasizing aspects of its histopathology different from those often portrayed and its differential diagnosis. Am J Surg Pathol 2014; 38: 1023–1032.Google Scholar

Levavi, H., Sabah, G., Heifetz, M., et al. Sclerosing peritonitis associated with bilateral luteinized thecoma, linked to anticonvulsant therapy. Eur J Gynaecol Oncol 2009; 30: 695–700.Google Scholar

Tian, T., Zhu, Q., Chen, W., et al. CT findings of sclerosing stromal tumor of the ovary: a report of two cases and review of the literature. Oncol Lett 2016; 11: 3817–3820.Google Scholar

Roth, L.M., Ramzy, I.. Signet ring stromal cell tumor revisited and related signet ring cell lesions of the ovary. Hum Pathol 2014; 45: 636–642.Google Scholar

Nistal, M., Martínez-García, C., Paniagua, R. Testicular fibroma. J Urol 1992; 147: 1617–1619.Google Scholar

Nistal, M., Puras, A., Perna, C., et al. Fusocellular gonadal stromal tumour of the testis with epithelial and myoid differentiation. Histopathology 1996; 29: 259–264.Google Scholar

Du, S., Powell, J., Hii, A., et al. Myoid gonadal stromal tumor: a distinct testicular tumor with peritubular myoid cell differentiation. Hum Pathol 2012; 43 :144–149.Google Scholar

Kao, C.S., Ulbright, T.M.. Myoid gonadal stromal tumor: a clinicopathologic study of three cases of a distinctive testicular tumor. Am J Clin Pathol 2014; 142: 675–682.Google Scholar

Seidman, J.D.. Unclassified ovarian gonadal stromal tumors: a clinicopathologic study of 32 cases. Am J Surg Pathol 1996; 20: 699–706.Google Scholar

Goswitz, J.J., Pettinato, G., Manivel, J.C.. Testicular sex cord-stromal tumors in children: clinicopathologic study of sixteen children with review of the literature. Pediatr Pathol Lab Med 1996; 16: 451–470.Google Scholar

Scully, R.E.. Gonadoblastoma: a gonadal tumor related to the dysgerminoma (seminoma) and capable of sex-hormone production. Cancer 1953; 6: 455–463.Google Scholar

Buell-Gutbrod, R., Ivanovic, M., Montag, A., et al. FOXL2 and SOX9 distinguish the lineage of the sex cord-stromal cells in gonadoblastomas. Pediatr Dev Pathol 2011; 14: 391–395.Google Scholar

Ulbright, T.M., Srigley, J.R., Reuter, V.E., et al. Sex cord-stromal tumors of the testis with entrapped germ cells: a lesion mimicking unclassified mixed germ cell sex cord-stromal tumors. Am J Surg Pathol 2000; 24: 535–542.Google Scholar